MDTMedtronic

$92.01

The financials

Medtronic by the numbers

Medtronic (MDT) reported revenue of $9.81B in Q4 2026 (quarter ended April 24, 2026), up 9.9% from the same quarter a year earlier. That came with a gross margin of 65% and net income of $1.24B (13% of revenue). For the full year FY2026, revenue was $36.4B (+8.4% year on year) and net income $4.80B. Its largest region in 2026-Q1 was Total Other Countries Excluding Ireland at $8.98B, 100% of the disclosed total, just ahead of Ireland at 0.4%.

Medtronic income statement, Q4 2026 against the same quarter a year earlier
Income statementQ4 2026Q4 2025Change
Revenue$9.81B$8.93B+9.9%
Gross profit$6.41B$5.78B+11%
Operating income$1.87B$1.44B+30%
Net income$1.24B$1.06B+18%
Diluted EPS$0.97$0.82+18%
Revenue by region, 2026-Q1, as reported to the SEC
GeographicRevenueShare
Total Other Countries Excluding Ireland$8.98B100%
Ireland$36M0.4%

Business Segments

Revenue split by geographic segment, from SEC XBRL filings.

Latest period: Q1 2026Total $9.02B (+0.62%)
Ireland grew +29% year on yearTotal Other Countries Excluding Ireland +8.7% year on year
  • Total Other Countries Excluding Ireland$8.98BQoQ +0.62%year on year +8.7%
  • Ireland$36.0MQoQ +2.9%year on year +29%
  • International-QoQ -year on year -
  • Total Other Countries Excluding United States And Ireland-QoQ -year on year -
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed 2026-02-24, SEC EDGAR